# Super-H Analytics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/super-h-analytics

- Industry: Software
- Headquarters: Columbus, US
- Website: www.mavenview.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Oct 24, 2017)
- Investors on record: 2

## About

Super-H Analytics, Inc. specializes in providing advanced business and medical intelligence solutions tailored for the life sciences sector, leveraging extensive data to foster informed decision-making.Super-H Analytics, Inc. was founded in 2015 in Columbus, US. The company focuses on delivering business intelligence software for the life sciences sector. The current CEO is Nicole Weidner. In October 2018, the company raised USD 0.3 million in venture funding from unspecified investors, marking its fourth deal to date. The total amount raised by the company is USD 0.3 million.MavenVue's primary offering is a sophisticated software platform that delivers business and medical intelligence tailored for professionals in the life sciences sector. This platform harnesses a vast database of over 200 million records to uncover critical relationships between various entities, including diseases, genes, drugs, and organizations. The software assists clients in identifying emerging technologies, potential competitors, and collaborators, as well as tracking funding and investment trends within healthcare. MavenVue primarily serves health and life science organizations, including research hospitals, pharmaceutical companies, and investors, enabling them to make informed decisions about their research investments and strategic directions. Geographically, MavenVue's products are utilized by clients across North America, Europe, and Asia, providing insights that drive innovation in healthcare.MavenVue generates revenue through a subscription-based model, targeting primarily B2B transactions with health and life science organizations. Clients typically engage with MavenVue by subscribing to its software platform for access to its comprehensive suite of analytical tools. The pricing structure accommodates various organizational sizes and needs, offering tiered subscription plans that provide different levels of access to data and analytical capabilities. The firm's flagship product integrates competitive intelligence and life science analytics, facilitating users in tracking funding flows and research trends while offering features to aid in technology transfer and commercialization strategies. This structured approach allows MavenVue to establish long-term partnerships with its clients, ensuring they receive ongoing support and updates as the healthcare landscape evolves.The company plans to leverage the recent funding of USD 0.3 million raised in October 2018 to enhance its software platform and expand its offerings. Future initiatives include the development of new analytical tools aimed at improving user access to competitive intelligence and funding insights. Moreover, Super-H Analytics, Inc. aims to penetrate additional markets in Europe and Asia by 2025, focusing on partnerships with local health organizations to tailor its products to specific regional needs.

## Funding rounds

- Seed, Oct 24, 2017, $0.8M — Ohio TechAngels - DUP, Rev1 Ventures
- Seed, Oct 10, 2016 — Rev1 Ventures

## Investors

- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Seed
- Ohio TechAngels - DUP — Seed